Textextraktion: pypdf | Seiten: 4
1 Decision of the Court of First Instance of the Unified Patent Court issued on 10 January 2025 CLAIMANT Abbott Diabetes Care Inc., 1360 South Loop Road, Alameda, CA 94502, USA, represented by CEO Robert Ford, at the same address, represented by: Dietrich Burkhard Kamlah, Taylor Wessing, Munich, Germany. DEFENDANTS 1. Dexcom Inc., 6340 Sequence Drive, CA 92121 San Diego, USA, rrepresented by CEO Kevin Sayer, at the same address, 2. Dexcom Deutschland GmbH, Haifa-Allee 2, 55128 Mainz, Germany, represented by the managing directors Michael Jon Brown, Alexander Frohlich and Jereme Michael Sylvain, at the same address, 3. Dexcom International Limited , 1 Lampousas Street, 1095 Nicosia, Cyprus, represented by director Jereme Michael Sylvain at the same address, all represented by: Marcus Grosch ...